دورية أكاديمية
Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)—a single region experience on consecutive patients
| العنوان: | Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)—a single region experience on consecutive patients |
|---|---|
| المؤلفون: | Eketorp Sylvan, S., Lundin, J., Ipek, M., Palma, M., Karlsson, C., Hansson, L. |
| المصدر: | Annals of Hematology. October 2014 93(10):1725-1733 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 09395555 14320584 |
|---|---|
| DOI: | 10.1007/s00277-014-2105-1 |